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OBJECTIVES: Proportion of days covered (PDC) is a common method to measure
medication acquisition behavior. Hospitalizations during an observation period
may impact PDC calculation, because independent medication acquisition behav-
ior during hospital stays is involuntary and cannot be accurately measured. The
purpose of this study was to examine three methods of adjusting for hospital days
when calculating PDC, and assess their impact on PDC. METHODS: Medical and
pharmacy claims from a commercial Midwestern insurer were used. Population
identification criteria included continuously enrolled subjects from January 2007 to
December 2009, with diabetes (medical claim with primary or secondary ICD-9
code 250.xx during 2008 also used to establish index date), no long-term care or
pregnancy, and age greater than 18 years. Observation period was defined as 365
days from index date. PDC (number of days supplied with diabetes drug / number
of days from first diabetes drug acquisition to observation end) was calculated in
three ways: 1) without hospital days adjustment; 2) adjusting the denominator for
hospital days; 3) adjusting the numerator and denominator for hospital days. One
way ANOVA and sensitivity analysis were used to examine the difference in PDC
estimates. RESULTS: A total of 24,072 subjects met study criteria and had mean
hospital days of 0.86 (SD7.09). PDC results were as follows: No hospital days
adjustment 66.16% (SD0.39), adjusting denominator 66.24% (SD0.39), and ad-
justing both numerator and denominator 66.33% (SD0.39). No significant differ-
ence among the three calculation methods was found (p0.889). Sensitivity anal-
ysis indicated that when average total hospital days reached approximately two
days, estimated non-adjusted PDC was significantly lower (p0.05).
CONCLUSIONS: Among subjects with diabetes followed for 365 days, mean total
hospital days was small, and impact on PDC calculations was non-significant. As
total hospital days increase, PDC estimates can be affected and adjusting for hos-
pital days should be considered.
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OBJECTIVES: The objectives of this study were to gain a better understanding of
patient preferences for the attributes of an electronic personal health record (ePHR)
service that supports diabetes self-management, and to gain an understanding of
any factors that might influence their preferences. METHODS: Adaptive choice-
based conjoint analysis was used to examine patient preferences. A web-based
survey was developed comprising six ePHR service attributes. Hierarchical Bayes
estimations were used to quantify patient preferences while Latent Class Analysis
was used to segment the sample. The Patient Activation Measure™ was used to
determine patient level of activation for diabetes self-management. Simulations
and sensitivity analyseswere run to uncover the complex effects of ePHR attributes
on the overall utility of the service. Patients’ willingness to pay was calculated
using simulations of preference shares for three commercially available ePHRs and
increasing the price of the dominant and lowest priced product until it was equally
preferred to its closest rival. RESULTS:A stratified sample of 150 patients with type
1 diabetes, type 2 diabetes, and Prediabetes were unwavering in their preferences
for an Internet-based ePHR service supplied by a physician or specialist. They also
preferred to exchange their health information with their physician or nurse, once
a month, at no cost. Monthly service fees were considered the most important
ePHR service attribute. Patient age and perceived health status are important con-
siderations when designing and marketing an ePHR service. Patients’ level of acti-
vation for diabetes self-management did not appear to play a major role in influ-
encing their preferences. CONCLUSIONS: This study yielded a patient-informed,
evidence-based ePHR service framework that supports diabetes self-management.
Adaptive choice-based conjoint analysis appears to be a useful method for quan-
tifying patient preferences and informing ePHR value propositions and system
design specifications.
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OBJECTIVES: We used a new US population dataset to quantify the burden of
chronic conditions (CCs), using the SF-36v2 Health Survey as a common metric to
test the incremental physical and mental health burden of a comorbid mental CC
among patients with physical CCs; and of a comorbid physical CC among patients
withmental CCs.METHODS:We created four groups: ‘Healthy’ (no lifetimemental
or physical CC); ‘Physical’ (told by MD they had 1 physical but no mental CCs);
‘Mental’ (told they had 1mental but no physical CCs); ‘Physical and Mental’ (1
mental and 1 physical CCs). Each CCwas further classified by diagnostic category.
Multivariate regression models, overall and within gender and diagnosis, yielded
group mean SF-36v2 PCS and MCS scores, controlling for age and group x age
interaction. RESULTS: As expected, the Physical and Mental groups had depressed
PCS andMCS scores (6–7 and 11-12 points, respectively) vs. Healthy subjects. In the
Physical group, a comorbid mental CC further depressed PCS and MCS (3-5 and
13-14 points). In the Mental group, a comorbid physical CC further depressed MCS
and PCS (3 and 10-11 points). Similarly, within the five Physical subgroups, a co-
morbid mental condition further depressed both PCS and MCS (3-5 and 13-15
points). For theMental group, each diagnostic subgroup further depressedMCS and
PCS (4-5 points and 11-16 points). All results persisted across gender.
CONCLUSIONS:Results confirmedour hypotheses. The presence of either a comor-
bid physical or mental CC led to further decrements in both PCS andMCS. Findings
underscore the complexity of managing patients with multiple CCs and impor-
tance of screening for and treating both physical and mental CCs to optimize pa-
tient outcomes. Longitudinal analysis is required to understand the implications of
comorbid CC patterns on health outcomes over time.
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OBJECTIVES: Lead toxicity has been labeled as a major health problem globally
with limited therapeutic options. Literature reveals controversial reports on the
lead detoxifying potential of vitamin C. The aim of this study was to see if vitamin
C supplementation reduces lead levels of blood in adult subjects exposed to lead.
METHODS: After ethical approval and informed consent the traffic police study
subjects (all male) were randomly divided into two groups each containing 40
subjects. One group received 500 mg vitamin C, while the second group was given
1000 mg orally daily for a period of one month. Blood samples were collected at 0,
15, and 30 days of treatment and lead levels were analyzed from the PCSIR Lab,
Karachi using atomic absorption spectrophotometer. RESULTS: The data showed
raised levels of lead in study subjects of both groups (21.74  1.62 and 22.51  1.28
mcg/dl; mean  SEM; N40) compared to the safe limit ( 10 mcg/dl) recom-
mended byWHO. The treatment with vitamin C (500mg) reduced the lead levels to
16.91  1.08 mcg/dl (N 29) after 15 days treatment (P0.01), while the lead level
after 30 days treatment was further reduced to12.61 1.50mcg/dl (N 36; p0.001
compared to control, 21.74  1.62). In the second group subjects, which received
1000mg vitamin C, the lead level after 15 days treatmentwas 15.800.89mcg/dl (N
33; P0.001)), with no further drop (P0.05) after 30 days treatment, as the resul-
tant lead level was 14.64 1.05mcg/dl (N31).CONCLUSIONS:These data indicate
that vitamin C has a dose and time-dependent lead-detoxifying effect and that
vitamin C supplementation may be an effective, safe and economical method in
reducing blood lead levels in chronically exposed subjects such as traffic police.
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Currently 15 US states have laws that regulate insurance coverage for fertility
treatments. Differences between stateswith a comprehensivemandate (2 in vitro
fertilization (IVF) cycles) and non-comprehensive mandate (2 cycles) has been
studied using CDCAssisted Reproductive Technology data, but less is known about
the managed care perspective. OBJECTIVES: To study the impact of state mandate
on in vitro fertilization (IVF) outcomes using a claims database. METHODS: Phar-
Metrics® data for patients with continuous eligibility for 12 months before and
after first gonadotropin-releasing hormone agonist or antagonist prescription (in-
dex date) between January 1, 1999 andMay 31, 2009. Patientswithout a prescription
for follicle stimulating hormone, human chorionic gonadatropin, or evidence of an
embryo transfer within 60 days of index were excluded. Patient descriptors were:
state mandate type (comprehensive versus non-comprehensive), age (38y,38y)
and year of IVF procedure (2005, 2005). ICD-9-CM code for live birth (V27.0,
V27.2, V27.3, V27.5, or V27.6)was evaluated through 42weeks post embryo transfer.
Logistic regression evaluated effects across variables. RESULTS: A total of 880 pa-
tients met study criteria. 49.4% resided in a comprehensive mandate state. Fewer
patients in comprehensive mandate states were identified prior to 2006 (52.0%)
versus non-comprehensive mandate states (58.9%) (P0.0389). The percentage of
patients aged38y was 23.0% in comprehensive versus 17.1% for non-comprehen-
sive mandate states (P0.0284). There was no difference in live births between
comprehensive and non-comprehensivemandate patients (49.2 and 51.5% respec-
tively; P0.5016). Logistic regression results showed that patients38y were more
likely to have a live birth (OR 2.70; 95%CI1.90-3.86); state mandate and year range
showed no association. There were no significant interactions. CONCLUSIONS:
The live birth rate from one IVF cycle in a managed care population was50% and
was not affected by state mandate. Patients with completed IVF before age 38
experienced almost 3 times greater odds of live birth.
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